Valsartan

Contraindicated

Valsartan Lisinopril Prinivil Explained Increased risk of angioedema and an increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal fun... Details Valsartan Aliskiren Tekturna An increased risk of hyperkalemia, renal impairment and hypotension Details Valsartan Benazepril Lotensin Increased risk of angioedema and an increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal fun... Details Valsartan Captopril Capoten® Increased risk of angioedema and an increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal fun... Details Valsartan Enalapril Epaned Increased risk of angioedema and an increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal fun... Details Valsartan Fosinopril Monopril® Increased risk of angioedema and an increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal fun... Details Valsartan Moexipril Univasc® Increased risk of angioedema and an increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal fun... Details Valsartan Perindopril Aceon Increased risk of angioedema and an increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal fun... Details

Major

Valsartan Cyclosporine Injection Atopica Increased valsartan exposure and an increased risk of hyperkalemia Details Valsartan Cyclosporine Ophthalmic Cequa Increased valsartan exposure and an increased risk of hyperkalemia Details Valsartan Darolutamide Nubeqa Increased exposure of OATP1B1 or OATP1B3 substrates Details Valsartan Digoxin Cardoxin® An increased digoxin exposure Details Valsartan Furosemide Injection Disal Severe hypotension and deterioration in renal function, including renal failure Details Valsartan Leniolisib Joenja Increased OATP1B1/OATP1B3 substrate exposure Details Valsartan Lithium Carbonate Lithobid Increased risk of lithium toxicity Details

Moderate

Valsartan Asenapine Transdermal Patch Secuado An increased risk of hypotension Details Valsartan Bromfenac Ophthalmic Bromday® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Diclofenac Ophthalmic Voltaren® Eye Drops Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Diclofenac Topical (Actinic Keratosis) Pennsaid Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Diclofenac Topical (Arthritis Pain) Pennsaid® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Diclofenac Transdermal Patch Flector Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Encorafenib Braftovi Increased OATP1B1 substrate exposure, increased OATP1B3 substrate exposure, increased risk of OATP1B1 substrate-related toxicities... Details Valsartan Etodolac Lodine Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Fenoprofen Fenopron Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Flurbiprofen Ansaid Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Flurbiprofen Ophthalmic Ocufen Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Ibuprofen Addaprin Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Insulin Degludec (Rdna Origin) Injection Ryzodeg® (as a combination product containing Insulin Degludec and Insulin Aspart) Increased risk of hypoglycemia Details Valsartan Insulin Detemir (Rdna Origin) Injection Levemir Increased risk of hypoglycemia Details Valsartan Insulin Glulisine (Rdna Origin) Injection Apidra Increased risk of hypoglycemia Details Valsartan Ketoprofen Actron® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Ketorolac Acular Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Ketorolac Injection Acular Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Ketorolac Nasal Spray Sprix Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Ketorolac Ophthalmic Acular Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Meclofenamate Meclodium® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Mefenamic Acid Ponstel® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Meloxicam Alloxate Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Meloxicam Injection Alloxate Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Valsartan Nabumetone Relafen Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details